- Home
- GECC vs SRTS Comparison
GECC vs SRTS Comparison
Compare GECC & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- SRTS
- Stock Information
- Founded
- GECC 2016
- SRTS 2010
- Country
- GECC United States
- SRTS United States
- Employees
- GECC N/A
- SRTS N/A
- Industry
- GECC Finance: Consumer Services
- SRTS Medical/Dental Instruments
- Sector
- GECC Finance
- SRTS Health Care
- Exchange
- GECC Nasdaq
- SRTS Nasdaq
- Market Cap
- GECC 106.1M
- SRTS 106.0M
- IPO Year
- GECC N/A
- SRTS 2016
- Fundamental
- Price
- GECC $10.13
- SRTS $8.93
- Analyst Decision
- GECC
- SRTS Strong Buy
- Analyst Count
- GECC 0
- SRTS 2
- Target Price
- GECC N/A
- SRTS $12.50
- AVG Volume (30 Days)
- GECC 13.2K
- SRTS 244.9K
- Earning Date
- GECC 10-31-2024
- SRTS 11-14-2024
- Dividend Yield
- GECC 13.79%
- SRTS N/A
- EPS Growth
- GECC N/A
- SRTS N/A
- EPS
- GECC 0.65
- SRTS 0.57
- Revenue
- GECC $39,468,000.00
- SRTS $41,308,000.00
- Revenue This Year
- GECC $16.95
- SRTS $55.14
- Revenue Next Year
- GECC $7.48
- SRTS $21.75
- P/E Ratio
- GECC $15.57
- SRTS $15.74
- Revenue Growth
- GECC 16.86
- SRTS 65.62
- 52 Week Low
- GECC $9.55
- SRTS $2.05
- 52 Week High
- GECC $11.82
- SRTS $9.20
- Technical
- Relative Strength Index (RSI)
- GECC 52.77
- SRTS 76.90
- Support Level
- GECC $9.99
- SRTS $6.70
- Resistance Level
- GECC $10.37
- SRTS $9.20
- Average True Range (ATR)
- GECC 0.15
- SRTS 0.54
- MACD
- GECC 0.02
- SRTS 0.22
- Stochastic Oscillator
- GECC 65.22
- SRTS 90.53
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.